BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33820943)

  • 21. Genome analyses of colistin-resistant high-risk bla
    Talat A; Khan F; Khan AU
    BMC Microbiol; 2024 May; 24(1):174. PubMed ID: 38769479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae.
    Poirel L; Jayol A; Bontron S; Villegas MV; Ozdamar M; Türkoglu S; Nordmann P
    J Antimicrob Chemother; 2015 Jan; 70(1):75-80. PubMed ID: 25190723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-occurrence of genes encoding carbapenemase, ESBL, pAmpC and non-β-Lactam resistance among Klebsiella pneumonia and E. coli clinical isolates in Tunisia.
    Ben Sallem R; Laribi B; Arfaoui A; Ben Khelifa Melki S; Ouzari HI; Ben Slama K; Naas T; Klibi N
    Lett Appl Microbiol; 2022 May; 74(5):729-740. PubMed ID: 35076956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of PhoPQ and PmrAB two component system alternations on colistin resistance from non-mcr colistin resistant clinical E. Coli strains.
    Wang CH; Siu LK; Chang FY; Tsai YK; Huang LY; Lin JC
    BMC Microbiol; 2024 Apr; 24(1):109. PubMed ID: 38565985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study.
    Olaitan AO; Diene SM; Kempf M; Berrazeg M; Bakour S; Gupta SK; Thongmalayvong B; Akkhavong K; Somphavong S; Paboriboune P; Chaisiri K; Komalamisra C; Adelowo OO; Fagade OE; Banjo OA; Oke AJ; Adler A; Assous MV; Morand S; Raoult D; Rolain JM
    Int J Antimicrob Agents; 2014 Dec; 44(6):500-7. PubMed ID: 25264127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates.
    Lomonaco S; Crawford MA; Lascols C; Timme RE; Anderson K; Hodge DR; Fisher DJ; Pillai SP; Morse SA; Khan E; Hughes MA; Allard MW; Sharma SK
    PLoS One; 2018; 13(6):e0198526. PubMed ID: 29883490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Mechanisms of Colistin Resistance Among Klebsiella Pneumoniae Strains.
    Borsa BA; Demirci M; Gungordu-Dalar Z; Karabiyik G; Aygun G; Kucukbasmaci O
    Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathways Regulating the pbgP Operon and Colistin Resistance in Klebsiella pneumoniae Strains.
    Choi MJ; Kim S; Ko KS
    J Microbiol Biotechnol; 2016 Sep; 26(9):1620-8. PubMed ID: 27238937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin.
    Jayol A; Poirel L; Brink A; Villegas MV; Yilmaz M; Nordmann P
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4762-6. PubMed ID: 24914122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the ISKpn element in mediating mgrB gene mutations in ST11 hypervirulent colistin-resistant
    Zhu L; Li P; Zhang G; He Z; Tao X; Ji Y; Yang W; Zhu X; Luo W; Liao W; Chen C; Liu Y; Zhang W
    Front Microbiol; 2023; 14():1277320. PubMed ID: 37840706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colistin Resistance in KPC-2- and SHV-5-Producing Klebsiella pneumoniae Clinical Isolates in Bulgaria.
    Savov E; Todorova I; Politi L; Trifonova A; Borisova M; Kioseva E; Tsakris A
    Chemotherapy; 2017; 62(6):339-342. PubMed ID: 28738348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and molecular characterisation of colistin-resistant Klebsiella pneumoniae isolates from immunocompromised patients in Tunisia.
    Tanfous FB; Raddaoui A; Chebbi Y; Achour W
    Int J Antimicrob Agents; 2018 Dec; 52(6):861-865. PubMed ID: 30176353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak.
    Halaby T; Kucukkose E; Janssen AB; Rogers MR; Doorduijn DJ; van der Zanden AG; Al Naiemi N; Vandenbroucke-Grauls CM; van Schaik W
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6837-6843. PubMed ID: 27600049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic Investigation of the Signal Transduction Pathways Controlling Colistin Resistance in Klebsiella pneumoniae.
    Cheung CHP; Dulyayangkul P; Heesom KJ; Avison MB
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32457105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colistin-resistant Klebsiella pneumoniae bloodstream infection: old drug, bad bug.
    Ben-Chetrit E; Mc Gann P; Maybank R; Stam J; Assous MV; Katz DE
    Arch Microbiol; 2021 Aug; 203(6):2999-3006. PubMed ID: 33774687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colistin Resistance and Extensive Genetic Variations in PmrAB and PhoPQ in Klebsiella Pneumoniae Isolates from South Korea.
    Cheong HS; Kim SY; Seo J; Wi YM; Peck KR; Ko KS
    Curr Microbiol; 2020 Sep; 77(9):2307-2311. PubMed ID: 32524274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of rapid polymyxin NP test to detect colistin-resistant Klebsiella pneumoniae isolated in a tertiary Greek hospital.
    Malli E; Florou Z; Tsilipounidaki K; Voulgaridi I; Stefos A; Xitsas S; Papagiannitsis CC; Petinaki E
    J Microbiol Methods; 2018 Oct; 153():35-39. PubMed ID: 30144479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colistin- and Carbapenem-Resistant Klebsiella pneumoniae Clinical_Isolates: Algeria.
    Yousfi H; Hadjadj L; Dandachi I; Lalaoui R; Merah A; Amoura K; Dahi A; Dekhil M; Messalhi N; Diene SM; Baron S; Rolain JM
    Microb Drug Resist; 2019 Mar; 25(2):258-263. PubMed ID: 30256174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Intra-Hospital Spread of Colistin-Resistant
    Popivanov G; Markovska R; Gergova I; Konaktchieva M; Cirocchi R; Kjossev K; Mutafchiyski V
    Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541237
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduced Fitness Costs of
    Giordano C; Klak A; Barnini S; Chlebowicz MA; Menconi M; Rossen JW; Friedrich AW; Bathoorn E
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31694895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.